1-4 of 4
Keywords: Advanced glycation end products
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tissue Advanced Glycation End Product Deposition after Kidney Transplantation

Available to Purchase
Subject Area:
Nephrology
Lisa E. Crowley, Catherine P. Johnson, Natasha McIntyre, Richard J. Fluck, Christopher W. McIntyre, Maarten W. Taal, Janson C.H. Leung
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2013) 124 (1-2): 54–59.
https://doi.org/10.1159/000355692
Published Online: 15 October 2013
...Lisa E. Crowley; Catherine P. Johnson; Natasha McIntyre; Richard J. Fluck; Christopher W. McIntyre; Maarten W. Taal; Janson C.H. Leung Background: Tissue advanced glycation end products (AGEs) accumulate in chronic kidney disease (CKD) and are a measure of cumulative metabolic stress. Measurement...
View articletitled, Tissue Advanced Glycation End Product Deposition after Kidney Transplantation
Open the PDF for Tissue Advanced Glycation End Product Deposition after Kidney Transplantation in another window
Journal Articles

Vitamin B 6 Metabolism in Chronic Kidney Disease – Relation to Transsulfuration, Advanced Glycation and Cardiovascular Disease

Available to Purchase
Subject Area:
Nephrology
Martin Busch, Andrea Göbert, Sybille Franke, Undine Ott, Jens Gerth, Andreas Müller, Günter Stein, Roland Bitsch, Gunter Wolf
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2010) 114 (1): c38–c46.
https://doi.org/10.1159/000245068
Published Online: 09 October 2009
.... Advanced glycation end products Cardiovascular disease Chronic kidney disease Pyridoxal phosphate Transsulfuration Vitamin B 6 CKD was staged according to K/DOQI Guidelines (stage 2–4: glomerular filtration rate 15–89 ml/min). In HD patients, HD was performed thrice weekly for 3.5–5 h. Forty...
View articletitled, Vitamin B 6 Metabolism in Chronic Kidney Disease – Relation to Transsulfuration, Advanced Glycation and Cardiovascular Disease
Open the PDF for Vitamin B 6 Metabolism in Chronic Kidney Disease – Relation to Transsulfuration, Advanced Glycation and Cardiovascular Disease in another window
Journal Articles

Serum Levels of the Advanced Glycation End Products N ε -Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension

Available to Purchase
Subject Area:
Nephrology
Martin Busch, Sybille Franke, Gunter Wolf, Richard D. Rohde, Günter Stein
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2008) 108 (4): c291–c297.
https://doi.org/10.1159/000127838
Published Online: 24 April 2008
... to a reduction in the serum levels of the advanced glycation end products (AGEs) pentosidine and N Ε -carboxymethyllysine (CML). Methods: One hundred and ninety-six patients of the Irbesartan in Diabetic Nephropathy Trial cohort (mean age 61 ± 6.5 years, 62 female, 134 male) with a mean estimated glomerular...
View articletitled, Serum Levels of the Advanced Glycation End Products N ε -Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension
Open the PDF for Serum Levels of the Advanced Glycation End Products N ε -Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension in another window
Journal Articles

Influence of Different Haemodialysis Modalities on AGE Peptide Levels: Intradialytic versus Long-Term Results

Available to Purchase
Subject Area:
Nephrology
Anne van Tellingen, Casper G. Schalkwijk, Tom Teerlink, Rob Barto, Muriel P.C. Grooteman, Tjeerd van der Ploeg, Piet M. ter Wee, Menso J. Nubé
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2005) 100 (1): c1–c7.
https://doi.org/10.1159/000084106
Published Online: 03 March 2005
...Anne van Tellingen; Casper G. Schalkwijk; Tom Teerlink; Rob Barto; Muriel P.C. Grooteman; Tjeerd van der Ploeg; Piet M. ter Wee; Menso J. Nubé Background: Peptide-linked degradation products of advanced glycation end products (AGE peptides) accumulate in chronic haemodialysis (HD) patients and may...
View articletitled, Influence of Different Haemodialysis Modalities on AGE Peptide Levels: Intradialytic versus Long-Term Results
Open the PDF for Influence of Different Haemodialysis Modalities on AGE Peptide Levels: Intradialytic versus Long-Term Results in another window